EMEIS SA (ORP.PA) Stock Price, Forecast & Analysis
Europe - EPA:ORP - FR001400NLM4 - Common Stock
ORP.PA Key Statistics, Chart & Performance
The current stock price of ORP.PA is 12.465 EUR. In the past month the price decreased by -11.26%. In the past year, price decreased by -99.32%.
ORP.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | N/A | 2.26B | ||
| CLARI.PA | CLARIANE SE | N/A | 1.22B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 993.51M | ||
| RHK.DE | RHOEN-KLINIKUM AG | 21.43 | 803.52M | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 14.33 | 465.43M | ||
| M12.DE | M1 KLINIKEN AG | 15.62 | 288.32M | ||
| LNA.PA | LNA SANTE | 11.5 | 262.39M | ||
| MED.DE | MEDICLIN AG | 4.82 | 162.45M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | 21.95 | 99.76M | ||
| MAK.DE | MATERNUS-KLINIKEN AG | N/A | 22.65M | ||
| EIF.DE | MEDNATION AG | 16.32 | 9.67M |
Related stock screener links
About ORP.PA
Company Profile
Orpea SA engages in the operation of geriatric healthcare facilities. The company is headquartered in Puteaux, Ile-De-France and currently employs 76,160 full-time employees. The company went IPO on 2002-04-16. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
Company Info
EMEIS SA
12 Rue Jean Jaures, Puteaux Cedex
Puteaux ILE-DE-FRANCE FR
Employees: 76160
Phone: 33147757807
EMEIS SA / ORP.PA FAQ
Can you describe the business of EMEIS SA?
Orpea SA engages in the operation of geriatric healthcare facilities. The company is headquartered in Puteaux, Ile-De-France and currently employs 76,160 full-time employees. The company went IPO on 2002-04-16. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
Can you provide the latest stock price for EMEIS SA?
The current stock price of ORP.PA is 12.465 EUR. The price increased by 1.24% in the last trading session.
Does EMEIS SA pay dividends?
ORP.PA does not pay a dividend.
What is the ChartMill rating of EMEIS SA stock?
ORP.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the Price/Earnings (PE) ratio of EMEIS SA (ORP.PA)?
The PE ratio for EMEIS SA (ORP.PA) is 1.2. This is based on the reported non-GAAP earnings per share of 10.36 and the current share price of 12.465 EUR.
What is the market capitalization of ORP stock?
EMEIS SA (ORP.PA) has a market capitalization of 1.98B EUR. This makes ORP.PA a Small Cap stock.
ORP.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ORP.PA. When comparing the yearly performance of all stocks, ORP.PA is a bad performer in the overall market: 96.95% of all stocks are doing better.
ORP.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA. ORP.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ORP.PA Financial Highlights
Over the last trailing twelve months ORP.PA reported a non-GAAP Earnings per Share(EPS) of 10.36. The EPS increased by 360.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.07% | ||
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| Debt/Equity | 4.3 |
ORP.PA Forecast & Estimates
9 analysts have analysed ORP.PA and the average price target is 170.74 EUR. This implies a price increase of 1269.72% is expected in the next year compared to the current price of 12.465.
For the next year, analysts expect an EPS growth of 99.7% and a revenue growth 6.41% for ORP.PA